Bleakley Financial Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
14,835
-3,913
-21% -$368K 0.01% 634
2026
Q1
$2.22M Buy
+18,748
New +$2.32M 0.03% 372
2025
Q1
Sell
-12,351
Closed -$2.01M 1040
2024
Q4
$2.01M Buy
12,351
+1,612
+15% +$288K 0.06% 259
2024
Q3
$2.1M Sell
10,739
-27,533
-72% -$5.07M 0.06% 247
2024
Q2
$6.63M Sell
38,272
-20,589
-35% -$3.43M 0.19% 102
2024
Q1
$9.96M Buy
58,861
+3,998
+7% +$749K 0.29% 67
2023
Q4
$10.8M Buy
54,863
+4,024
+8% +$712K 0.34% 57
2023
Q3
$8.84M Buy
50,839
+1,504
+3% +$273K 0.31% 64
2023
Q2
$8.5M Buy
49,335
+5,832
+13% +$1.01M 0.27% 75
2023
Q1
$7.24M Buy
43,503
+16,773
+63% +$2.75M 0.24% 82
2022
Q4
$3.92M Buy
+26,730
New +$3.96M 0.14% 144

Other funds holding ZTS

Bleakley Financial Group's ZTS Position: Q2 2026 in Review

Bleakley Financial Group reduced its Zoetis (ZTS) stake by 21% in Q2 2026, selling an estimated $368K and leaving 14,835 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #634.

Bleakley Financial Group first reported a position in ZTS in Q4 2022 and has held it in 11 quarters since. The position peaked at $10.8M in Q4 2023. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Bleakley Financial Group held 14,835 shares of Zoetis worth $1.07M as of Q2 2026.
  • Bleakley Financial Group sold 3,913 Zoetis shares in Q2 2026, an estimated $368K.
  • Zoetis made up 0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #634 holding.
  • Bleakley Financial Group first reported a position in Zoetis in Q4 2022 and has held it in 11 quarters since.
  • Bleakley Financial Group's Zoetis position peaked at $10.8M in Q4 2023.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.